RightFit Trial Directory

Leukemia clinical trials in Miami, FL

27 recruiting leukemia studies with a site in Miami, FL.

All trials in Miami, FL · All Leukemia trials

RecruitingPhase 3NCT03150693

Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia

Sponsor: Alliance for Clinical Trials in Oncology

Fort Lauderdale, FL · Hollywood, FL · Miami, FL · +452 more sites

RecruitingPhase 2NCT06317662

Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia

Sponsor: National Cancer Institute (NCI)

Gainesville, FL · Hollywood, FL · Jacksonville, FL · +112 more sites

RecruitingPhase 2NCT05554393

Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)

Sponsor: National Cancer Institute (NCI)

Miami, FL · Pembroke Pines, FL · +173 more sites

RecruitingPhase 2NCT06317649

Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)

Sponsor: National Cancer Institute (NCI)

Gainesville, FL · Miami, FL · +223 more sites

RecruitingPhase 2NCT06672146

Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)

Sponsor: National Cancer Institute (NCI)

Hollywood, FL · Miami, FL · Pembroke Pines, FL · +132 more sites

RecruitingPhase 3NCT07007312

Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML

Sponsor: Kura Oncology, Inc.

Miami, FL · Tampa, FL · +42 more sites

RecruitingPhase 3NCT07277231

A Study to Investigate Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Acalabrutinib in Adults With Previously Untreated Chronic Lymphocytic Leukemia

Sponsor: BeOne Medicines

Jacksonville, FL · Miami, FL · Tampa, FL · +19 more sites

RecruitingPhase 3NCT04293562

A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

Sponsor: Children's Oncology Group

Fort Lauderdale, FL · Fort Myers, FL · Gainesville, FL · +183 more sites

RecruitingPhase 2NCT06504459

Venetoclax in Combination With Cladribine and Cytarabine Alternating With Azacitidine Plus Venetoclax for the Treatment of Newly Diagnosed Monocytic AML and Active Signaling Mutated AML

Sponsor: OHSU Knight Cancer Institute

Miami, FL · +1 more sites

RecruitingPhase 2NCT06566742

A Phase 2 Study Evaluating Olutasidenib in Patients With IDH1-mutated Clonal Cytopenia of Undetermined Significance and Lower-risk Myelodysplastic/Syndromes/Chronic Myelomonocytic Leukemia.

Sponsor: M.D. Anderson Cancer Center

Miami, FL · +1 more sites

RecruitingPhase 1NCT05010005

A Study of Ruxolitinib and Duvelisib in People With Lymphoma

Sponsor: Memorial Sloan Kettering Cancer Center

Miami, FL · +8 more sites

RecruitingPhase 1 / Phase 2NCT05322850

Phase I/II Trial: Engineered Donor Graft (Orca Q) for Pediatric Hematopoietic Cell Transplant (HCT)

Sponsor: University of Florida

Gainesville, FL · Miami, FL · +1 more sites

RecruitingPhase 1NCT05857969

Ex Vivo Drug Sensitivity Testing and Multi-Omics Profiling

Sponsor: Florida International University

Miami, FL

RecruitingPhase 1 / Phase 2NCT04726241

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

Sponsor: PedAL BCU, LLC

Fort Lauderdale, FL · Fort Myers, FL · Gainesville, FL · +161 more sites

RecruitingNot applicableNCT07469592

eHealth Mindfulness-based Music Therapy Intervention for Patients Undergoing Stem Cell Transplantation

Sponsor: University of Miami

Miami, FL

RecruitingPhase not listedNCT02560883

Hairy Cell Leukemia Patient Data Registry

Sponsor: Ohio State University Comprehensive Cancer Center

Miami, FL · Miami Beach, FL · +3 more sites

RecruitingPhase 1NCT05131022

A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies

Sponsor: Nurix Therapeutics, Inc.

Miami, FL · Sarasota, FL · +16 more sites

RecruitingPhase not listedNCT05430971

Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) International Registry

Sponsor: Immune Oncology Research Institute

Miami, FL · Tampa, FL · +1 more sites

RecruitingPhase not listedNCT05978141

A Registry for People With T-cell Lymphoma

Sponsor: Memorial Sloan Kettering Cancer Center

Miami, FL · Tampa, FL · +24 more sites

RecruitingPhase 2NCT06588478

A Study Evaluating the Efficacy and Safety of Pirtobrutinib in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Sponsor: Loxo Oncology, Inc.

Miami, FL · +20 more sites

RecruitingPhase 2NCT06782542

Olutasidenib, Venetoclax, and Azacitidine in IDH1 Mutated Newly Diagnosed Acute Myeloid Leukemia Patients Eligible for Intensive Induction Chemotherapy

Sponsor: Justin Watts, MD

Miami, FL

RecruitingPhase 1 / Phase 2NCT04988555

A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)

Sponsor: Sumitomo Pharma America, Inc.

Miami, FL · Tampa, FL · +30 more sites

RecruitingPhase 2NCT07218510

Venetoclax and Obinutuzumab Followed by Epcoritamab for the Treatment of Untreated Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma, LonGEVity Trial

Sponsor: City of Hope Medical Center

Miami, FL · +6 more sites

RecruitingPhase 4NCT06876649

A Master Protocol to Evaluate the Long-Term Safety of (LY3527727) Pirtobrutinib

Sponsor: Eli Lilly and Company

Jacksonville, FL · Miami, FL · Sarasota, FL · +17 more sites

RecruitingPhase 1NCT05597306

Venetoclax and Bomedemstat in Patients With Relapsed/Refractory Acute Myeloid Leukemia

Sponsor: Terrence J Bradley, MD

Miami, FL

RecruitingPhase 1NCT06501196

A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Higher Risk Myelodysplastic Syndrome

Sponsor: BlossomHill Therapeutics

Miami, FL · Tampa, FL · +11 more sites

Not yet recruitingPhase 2NCT05565105

CD34+ Transplants for Myeloid Malignancies

Sponsor: Guenther Koehne

Miami, FL

Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.